447 related articles for article (PubMed ID: 30209565)
1. Intranasal co-administration of recombinant active fragment of Zonula occludens toxin and truncated recombinant EspB triggers potent systemic, mucosal immune responses and reduces span of E. coli O157:H7 fecal shedding in BALB/c mice.
Shekar A; Ramlal S; Jeyabalaji JK; Sripathy MH
Med Microbiol Immunol; 2019 Feb; 208(1):89-100. PubMed ID: 30209565
[TBL] [Abstract][Full Text] [Related]
2. Intranasal immunization of cocktail/fusion protein containing Tir along with ΔG active fragment of Zot as mucosal adjuvant confers enhanced immunogenicity and reduces E. coli O157:H7 shedding in mice.
Shekar A; Ramlal S; Jeyabalaji JK; Sripathy MH
Int Immunopharmacol; 2018 Oct; 63():211-219. PubMed ID: 30103196
[TBL] [Abstract][Full Text] [Related]
3. Efficacy of a recombinant Intimin, EspB and Shiga toxin 2B vaccine in calves experimentally challenged with Escherichia coli O157:H7.
Martorelli L; Garimano N; Fiorentino GA; Vilte DA; Garbaccio SG; Barth SA; Menge C; Ibarra C; Palermo MS; Cataldi A
Vaccine; 2018 Jun; 36(27):3949-3959. PubMed ID: 29807709
[TBL] [Abstract][Full Text] [Related]
4. Subcutaneous and intranasal immunization with Stx2B-Tir-Stx1B-Zot reduces colonization and shedding of Escherichia coli O157:H7 in mice.
Zhang XH; He KW; Zhang SX; Lu WC; Zhao PD; Luan XT; Ye Q; Wen LB; Li B; Guo RL; Wang XM; Lv LX; Zhou JM; Yu ZY; Mao AH
Vaccine; 2011 May; 29(22):3923-9. PubMed ID: 21338683
[TBL] [Abstract][Full Text] [Related]
5. Subcutaneous and intranasal immunization with type III secreted proteins can prevent colonization and shedding of Escherichia coli O157:H7 in mice.
Babiuk S; Asper DJ; Rogan D; Mutwiri GK; Potter AA
Microb Pathog; 2008 Jul; 45(1):7-11. PubMed ID: 18487034
[TBL] [Abstract][Full Text] [Related]
6. Reduced faecal shedding of Escherichia coli O157:H7 in cattle following systemic vaccination with γ-intimin C₂₈₀ and EspB proteins.
Vilte DA; Larzábal M; Garbaccio S; Gammella M; Rabinovitz BC; Elizondo AM; Cantet RJ; Delgado F; Meikle V; Cataldi A; Mercado EC
Vaccine; 2011 May; 29(23):3962-8. PubMed ID: 21477674
[TBL] [Abstract][Full Text] [Related]
7. Vaccination with killed whole-cells of Escherichia coli O157:H7 hha mutant emulsified with an adjuvant induced vaccine strain-specific serum antibodies and reduced E. coli O157:H7 fecal shedding in cattle.
Sharma VK; Schaut RG; Loving CL
Vet Microbiol; 2018 Jun; 219():190-199. PubMed ID: 29778196
[TBL] [Abstract][Full Text] [Related]
8. The intranasal vaccination of pregnant dams with Intimin and EspB confers protection in neonatal mice from Escherichia coli (EHEC) O157:H7 infection.
Rabinovitz BC; Larzábal M; Vilte DA; Cataldi A; Mercado EC
Vaccine; 2016 May; 34(25):2793-7. PubMed ID: 27129423
[TBL] [Abstract][Full Text] [Related]
9. Mucosal priming of the murine immune system against enterohemorrhagic Escherichia coli O157:H7 using Lactococcus lactis expressing the type III secretion system protein EspB.
Ahmed B; Loos M; Vanrompay D; Cox E
Vet Immunol Immunopathol; 2013 Mar; 152(1-2):141-5. PubMed ID: 23102992
[TBL] [Abstract][Full Text] [Related]
10. Physiopathological effects of Escherichia coli O157:H7 inoculation in weaned calves fed with colostrum containing antibodies to EspB and Intimin.
Rabinovitz BC; Vilte DA; Larzábal M; Abdala A; Galarza R; Zotta E; Ibarra C; Mercado EC; Cataldi A
Vaccine; 2014 Jun; 32(30):3823-9. PubMed ID: 24797699
[TBL] [Abstract][Full Text] [Related]
11. Oral immunization with Lactococcus lactis-expressing EspB induces protective immune responses against Escherichia coli O157:H7 in a murine model of colonization.
Ahmed B; Loos M; Vanrompay D; Cox E
Vaccine; 2014 Jun; 32(31):3909-16. PubMed ID: 24877767
[TBL] [Abstract][Full Text] [Related]
12. Intranasal immunization with novel EspA-Tir-M fusion protein induces protective immunity against enterohemorrhagic Escherichia coli O157:H7 challenge in mice.
Lin R; Zhu B; Zhang Y; Bai Y; Zhi F; Long B; Li Y; Wu Y; Wu X; Fan H
Microb Pathog; 2017 Apr; 105():19-24. PubMed ID: 28163157
[TBL] [Abstract][Full Text] [Related]
13. Oral immunization with attenuated Salmonella vaccine expressing Escherichia coli O157:H7 intimin gamma triggers both systemic and mucosal humoral immunity in mice.
Oliveira AF; Cardoso SA; Almeida FB; de Oliveira LL; Pitondo-Silva A; Soares SG; Hanna ES
Microbiol Immunol; 2012 Aug; 56(8):513-22. PubMed ID: 22671942
[TBL] [Abstract][Full Text] [Related]
14. Vaccination with attenuated Salmonella enterica Dublin expressing E coli O157:H7 outer membrane protein Intimin induces transient reduction of fecal shedding of E coli O157:H7 in cattle.
Khare S; Alali W; Zhang S; Hunter D; Pugh R; Fang FC; Libby SJ; Adams LG
BMC Vet Res; 2010 Jul; 6():35. PubMed ID: 20609252
[TBL] [Abstract][Full Text] [Related]
15. [The study for the immuno-protection of E. coli O157:H7 outer membrane protein].
Zhang Y; Lu SQ; Zhang YZ; Zhao BX; Xu JG
Zhonghua Yi Xue Za Zhi; 2004 Jan; 84(1):58-62. PubMed ID: 14990161
[TBL] [Abstract][Full Text] [Related]
16. Development of a Gold Nanoparticle Vaccine against Enterohemorrhagic Escherichia coli O157:H7.
Sanchez-Villamil JI; Tapia D; Torres AG
mBio; 2019 Aug; 10(4):. PubMed ID: 31409688
[TBL] [Abstract][Full Text] [Related]
17. Prevention of EHEC infection by chitosan nano-structure coupled with synthetic recombinant antigen.
Khanifar J; Hosseini RH; Kazemi R; Ramandi MF; Amani J; Salmanian AH
J Microbiol Methods; 2019 Feb; 157():100-107. PubMed ID: 30633949
[TBL] [Abstract][Full Text] [Related]
18. Immune Response in Calves Vaccinated with Type Three Secretion System Antigens and Shiga Toxin 2B Subunit of Escherichia coli O157:H7.
Martorelli L; Garbaccio S; Vilte DA; Albanese AA; Mejías MP; Palermo MS; Mercado EC; Ibarra CE; Cataldi AA
PLoS One; 2017; 12(1):e0169422. PubMed ID: 28046078
[TBL] [Abstract][Full Text] [Related]
19. Development and preclinical evaluation of safety and immunogenicity of an oral ETEC vaccine containing inactivated E. coli bacteria overexpressing colonization factors CFA/I, CS3, CS5 and CS6 combined with a hybrid LT/CT B subunit antigen, administered alone and together with dmLT adjuvant.
Holmgren J; Bourgeois L; Carlin N; Clements J; Gustafsson B; Lundgren A; Nygren E; Tobias J; Walker R; Svennerholm AM
Vaccine; 2013 May; 31(20):2457-64. PubMed ID: 23541621
[TBL] [Abstract][Full Text] [Related]
20. Efficient immune responses against Intimin and EspB of enterohaemorragic Escherichia coli after intranasal vaccination using the TLR2/6 agonist MALP-2 as adjuvant.
Cataldi A; Yevsa T; Vilte DA; Schulze K; Castro-Parodi M; Larzábal M; Ibarra C; Mercado EC; Guzmán CA
Vaccine; 2008 Oct; 26(44):5662-7. PubMed ID: 18675866
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
